Esokalli Slimming Microcrystalline Patch
Product Images NDC 84778-078

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Esokalli Slimming Microcrystalline Patch (NDC 84778-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Guangzhou Yixin Cross-border E-commerce Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (20250828 01)

1 (20250828 01)
This text is a description of a slimming microcrystalline patch that supports weight management. The patch contains Retatrutide 20mg and utilizes soluble microneedle technology for sustained release delivery. It is recommended to apply the patch once a week. The active ingredient helps in weight management and blood sugar control. The patch is suitable for adults with type 2 diabetes mellitus. Users are advised to monitor blood glucose regularly and seek medical help if experiencing certain symptoms. The patch should be applied to the wrist or the back of the user for best results. Additionally, the product should be kept out of reach of children.*
FDA Label Image

2 (20250828 02)

2 (20250828 02)
This is a description of a "Slimming Microcrystalline Patch" from a brand using core technology and soluble microneedle technology. The patch contains Retatrutide 20mg and is designed to support weight management by controlling sugar intake and aiding in the management of type 2 diabetes mellitus. Users are advised to monitor blood glucose regularly and watch for hypersensitivity reactions. The patch should be applied once a week for long-lasting results. Caution is advised for individuals with gastrointestinal disorders or rhythm problems. It is produced in China and has a shelf life mentioned.*
FDA Label Image

3 (20250828 03)

3 (20250828 03)
Description: The Slimming Microcrystalline Patch is designed to support weight management through the use of Retatrutide 20mg. This patch utilizes advanced technology for sustained-release delivery and is applied once a week. The active ingredient aids in weight management and blood sugar control, complementing a healthy diet and exercise routine. This external-use patch includes soluble microneedle technology and is suitable for individuals looking for additional support in their weight management journey.*
FDA Label Image

4 (20250828 04)

4 (20250828 04)
This text describes a slimming microcrystalline patch used for weight management and improving glycemic control in adults. The patch is applied once a week with long-acting delivery. It contains Retatrutide as the active ingredient and helps with blood sugar control. The directions and precautions for use are also outlined, including monitoring blood glucose levels and potential side effects like hypoglycemia. It is recommended to consult a doctor before use for those with certain medical conditions. The patch should be stored properly to maintain effectiveness.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.